Contact

Champions Oncology, Inc.

One University Plaza
Suite 307
Hackensack, NJ 07601
USA
Phone: 201.808.8400
Toll Free: 866.746.5457

Science & Technology Park at Johns Hopkins
855 N. Wolfe Street
Suite 619
Baltimore, MD 21205
USA
Phone: 410.369.0365
Toll Free: 866.746.5457
Fax: 410.369.0390

Champions Oncology UK Ltd.

London BioScience Innovation Centre
2 Royal College Street
London NW1 0NH
United Kingdom
Tel: +44 (0)20 7691 4925

Champions Oncology (Israel) Ltd.

17 HaTidhar Street, 2nd Floor
PO Box 4109
Ra’anana, Israel 43100

Send us an e-mail:

Inquiring about cancer reatment options? Please use this form.
Inquiring about translational oncology solutions? Please use this form.

For general inquiries:

  • What is your full name?

  • Please provide either an e-mail address or a phone number:

  • What can we help you with?

References:

  1. Hidalgo M et al. Activity of gemcitabine in direct patient derived xenografts predicts clinical outcome: validation of an in vivo model for drug development. J Clin Oncol 27:15s, 2009 (suppl; abstr 4528)
  2. Hidalgo M et al. A Pilot Study of Treatment Guided by Personalized Tumorgrafts in Patients with Advanced Cancer. Mol Cancer Ther August 2011 10:1311-1316
  3. Rubio-Viqueira B, Jimeno A, Cusatis G, et al. An in vivo platform for translational drug development in pancreatic cancer. Clin Cancer Res. 2006;12:4652-4661.
  4. Champions data on file.